JANICE XU: Open Payments
NPI 1952873127 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,119 in 26 payments from 13 companies in 2025. Trend: 2023 $220 · 2024 $530 · 2025 $2,119
Food & beverage: $2,043Education: $75
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 2 | $284 |
| ABBVIE INC. | 2 | $235 |
| Lilly USA, LLC | 3 | $215 |
| Amgen Inc. | 6 | $206 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $197 |
| Phathom Pharmaceuticals, Inc. | 1 | $150 |
| BridgeBio Pharma, Inc. | 1 | $133 |
| Ardelyx, Inc. | 1 | $124 |
| Gilead Sciences, Inc. | 1 | $122 |
| Novo Nordisk Inc | 1 | $119 |
Products named: REZDIFFRA, JARDIANCE, VOQUEZNA, Attruby, REPATHA, IBSRELA, Biktarvy, CREON.
Industry payments across IL — which companies pay providers there.
